Comparison of Stress Reduction Techniques

Stress Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02098018
• Other study ID #: R34AT007197
• Status: Completed
• Phase: N/A
• First received: March 18, 2014
• Last updated: August 1, 2016
• Start date: April 2015
• Est. completion date: August 2016

Study information

• Verified date: August 2016
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Westat
• Study type: Interventional

Clinical Trial Summary

There are many ways to reduce stress. This study will compare 2 different programs for reducing stress. In addition to looking at how well the programs reduce stress, we will also ask questions about how these programs may be working.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: August 2016
• Est. primary completion date: June 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 25 Years to 50 Years

Eligibility

Inclusion Criteria:

• 25-50 years of age

• Able to engage in moderate physical activity

• Interested in being treated for stress

Exclusion Criteria:

• Use of psychotropic medications within 6 months prior to study.

• History of extreme physical or psychological trauma.

• Medical conditions that would interfere with study procedures or confound results, such as diabetes, pregnancy, or paralysis.

• Axis I psychiatric diagnosis; e.g., history of substance use disorder, psychotic disorder, bipolar disorder, or eating disorder.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Stress

Intervention

Behavioral:
• Program 2
A well-established behavioral method for reducing stress. To maintain blinding, details will be given to participants after randomization.
• Program 1
A well-established behavioral method for reducing stress. To maintain blinding, details will be given to participants after randomization.

Locations

Country	Name	City	State
United States	Massachusettts General Hospital	Boston	Massachusetts
United States	University of Connecticut- Storrs	Storrs	Connecticut

Sponsors (2)

Lead Sponsor	Collaborator
Massachusetts General Hospital	University of Connecticut

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Perceived Stress	Participants will complete a short questionnaire about how stressed they feel. There will be 4 time points: baseline, week 8, week 12, week 24.	baseline to 24 weeks	No